title: In reference to Usery JB et al. (J Neuro-oncol. 2010 Feb 10).
authors.forename: M
authors.initials: M
authors.lastname: Maschio
authors.forename: L
authors.initials: L
authors.lastname: Dinapoli
authors.forename: B
authors.initials: B
authors.lastname: Jandolo
mesh_terms: D001932:Brain Neoplasms / Q000188:drug therapy*; D006801:Humans; D000077287:Levetiracetam; D018697:Nootropic Agents / Q000627:therapeutic use*; D010889:Piracetam / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011446:Prospective Studies
chemical_list: D018697:Nootropic Agents; D000077287:Levetiracetam; D010889:Piracetam
references.citation: Lancet Neurol. 2007 May;6(5):421-30
references.pmid: 17434097
references.citation: J Neurooncol. 2006 Oct;80(1):97-100
references.pmid: 16685465
references.citation: Semin Oncol. 2003 Dec;30(6 Suppl 19):49-52
references.pmid: 14765386
references.citation: Clin Ther. 2008 Aug;30(8):1385-407
references.pmid: 18803983
references.citation: J Neurooncol. 2010 Sep;99(2):251-60
references.pmid: 20146087
references.citation: Curr Neurol Neurosci Rep. 2005 May;5(3):207-13
references.pmid: 15865886
references.citation: J Child Neurol. 2002 Jan;17 Suppl 1:S53-7
references.pmid: 11918464
references.citation: Lancet Neurol. 2003 Aug;2(8):473-81
references.pmid: 12878435
references.citation: Clin Pharmacokinet. 2004;43(11):707-24
references.pmid: 15301575
references.citation: Seizure. 2003 Dec;12(8):585-6
references.pmid: 14630498